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In this issue of Cell Stem Cell, Chen et al. (2010) and Ohgushi et al. (2010) report that Rho-mediated actomy-
osin contractility underlies the proclivity of human embryonic stem cells to undergo apoptosis upon disso-
ciation or during low-density propagation, a property that challenges their in vitro isolation andmanipulation.Human embryonic stem cells (hESCs)
offer the promise of revolutionizing thera-
pies for the regeneration, improvement,
or replacement of tissues and organs
compromised by damage or disease.
Although murine embryonic stem cells
(mESCs) have been used in research for
several decades, methods developed for
their culture have proven to be inadequate
for the propagation and manipulation of
hESCs. Chief among their differences is
the propensity of hESCs to undergo
apoptosis upon dissociation or growth
at low cell density or in suspension,
whereas mESCs proliferate under the
same conditions. These properties make
it difficult to genetically modify hESCs,
a process that typically requires clonal
expansion from single successfully tar-
geted cells. In this issue of Cell Stem
Cell, Ohgushi et al. (2010) and Chen
et al. (2010) now show that activation
of the Rho-ROCK pathway leading to
enhanced actomyosin contraction plays
a critical role in dissociation-induced apo-
ptosis of hESCs.
Since the first successful isolation of
hESCs (Thomson et al., 1998), the field
has progressed rapidly to develop tech-
niques for their long-term culture, genetic
manipulation, and differentiation into ther-
apeutically relevant lineages. In 2007, a
cell-based screen of biologically active
compounds identified the selective ROCK
inhibitor Y27632 as a promoter of survival
and proliferation of dissociated hESCs
(Watanabe et al., 2007). Numerous
publications swiftly followed, reporting
that Y27632 supplementation greatly en-
hanced hESC survival in various contexts,
as well as aided in the recovery and
growth of cryopreserved hESCs. As a
result, ROCK inhibitors began to be
routinely used in hESC culture (reviewed
in Krawetz et al., 2009; Olson, 2008). The
race then was on to uncover the mecha-nism underlying the ability of Y27632 to
promote hESC survival.
The ROCK1 and ROCK2 serine/threo-
nine kinases are central and critical
regulators of actomyosin contractility.
Typically, these kinases are activated
by association with active GTP-bound
Rho proteins. However, ROCK1 may also
become activated by caspase-mediated
cleavage, resulting in contraction and
membrane blebbing during the late exe-
cution phase of apoptosis (Coleman
et al., 2001). ActiveROCKpromotesmem-
brane blebbing through a dual mecha-
nism of simultaneously phosphorylating
and activating the contractile force-gener-
ating regulatory myosin light chain (MLC)
and the LIM kinases, which modulate fila-
mentous actin stability. The resulting con-
tractility of the actomyosin cytoskeleton
leads to disequilibration in intracellular
hydrostatic pressures, detachment of the
plasmamembrane from anchorage points
with the cortical cytoskeleton, and conse-
quent membrane blebbing (Charras et al.,
2005).
Chen et al. (2010) and Ohgushi et al.
(2010) have now carefully dissected the
steps leading to actomyosin contraction
in dissociated hESCs (Figure 1). Chen
et al. (2010) found (by using blebbistatin
to inhibit the myosin heavy chain ATPase,
actin-disrupting agents, or independent
siRNA-mediated knockdown of either
ROCK1/ROCK2 or myosin heavy and
light chains) that the actomyosin contrac-
tile machinery is indispensable for both
the membrane blebbing and apoptosis
that follow dissociation. Ohgushi et al.
(2010) observed that Rho activation,
coupled with Rac inhibition, is a major
driver of dissociation-induced hESC apo-
ptosis via ROCK-mediated MLC phos-
phorylation, and that activation of ROCK1
by caspase-mediated cleavage does not
contribute. Interestingly, overexpressionCell Stem Celof an active form of Ezrin, which
strengthens the physical coupling be-
tween the plasma membrane and cortical
actin cytoskeleton, blocked blebbing but
not dissociation-induced cell death, indi-
cating that apoptosis was the result of
actomyosin contraction but not blebbing
per se. They then focused on the role of
E-cadherin in maintaining cell-cell adhe-
sions and promoting hESC viability. Loss
of these adhesions by treatment of aggre-
gated hESCs with a Ca2+ chelator to
reduce the strength of cadherin-cadherin
interactions, incubation with an E-cad-
herin blocking antibody, or siRNA-medi-
ated knockdown of E-cadherin resulted
in blebbing and apoptosis. However,
dissociated hESCs grown on E-cadherin-
coated plates still exhibited membrane
blebbing and reduced survival, indicating
that homotypic E-cadherin interactions
alone were insufficient to promote sur-
vival. These observations point to an
unknown sensor (denoted by question
mark in Figure 1) that transduces an
additional signal derived from cell-cell
adhesion that acts in conjunction with, or
in parallel to, E-cadherin activation to
repress actomyosin contractility and
consequent cell death.
To identify the RhoGEF(s) involved in
activating Rho in dissociated hESCs,
Ohgushi et al. (2010) performed an shRNA
screen and found that the dual Rho-GEF/
Rac-GAP protein Abr is required for
dissociation-induced apoptosis, intrigu-
ingly suggesting a role for reciprocal
Rho activation and Rac inactivation in
this process. Indeed, constitutively active
Rac strongly suppressed both membrane
blebbing and apoptosis in dissociated
hESCs. Finally, Ohgushi et al. (2010)
showed that unlike mESCs, epiblast-de-
rived mouse stem cells (mEpiSC), which
share a common origin to hESCs (Fig-
ure 1), or mESCs differentiated in vitrol 7, August 6, 2010 ª2010 Elsevier Inc. 135
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Figure 1. Survival of Dissociated Embryonic Stem Cells
(A) mESCs are derived from themesenchymal-like inner cell mass (ICM) of the
blastocyst, whereas hESCs are derived from the more polarized and epithe-
lium-like epiblast of the human embryo.
(B) In ICM-derived stem cells, Abr remains inactive in both aggregated
and dissociated conditions irrespective of E-cadherin activation. In epiblast-
derived stem cells, Abr is inactive under conditions where E-cadherin-
mediated cell-cell contacts are maintained. On dissociation, an unknown
mechanism activates the Rho-GEF and Rac-GAP activities of Abr, elevating
actomyosin contractility through the Rho-ROCK signaling pathway, leading
to cell membrane blebbing and apoptosis.
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strongly activated the Rho-
ROCK-actomyosin axis on
dissociation, concluding that
dissociation-induced apopto-
sis of hESCs is a feature of
their epiblast origin rather
than their species.
Together, these two papers
provide us with novel insights
into embryonic stem cell
physiology and underline the
importance of the tissue of
origin of these cells. Although
the dissociation-induced cell
death was linked back to
mitochondrial depolarization
and cytochrome c release,
further study will be required
to determine how actomyosin
contractility is coupled to
the mitochondrial pathway of
apoptosis. It will also be im-
portant to identify the sensor
that acts in concert with
E-cadherin activation to pro-
mote hESC survival. One pos-
sibility is that pulling forces
from adjacent cells in an
epithelial sheet counteract
the actomyosin contraction
within individual cells such
that these forces become
balanced in all directions
along the epithelial plane,
thereby limiting their proa-
poptotic effects. Because
mESCs are derived from the
inner cell mass prior to differ-
entiation into epithelial-type
cells, they may not be depen-dent on the tension generated by cell-cell
adhesions, such as those that occur in an
epithelial sheet, for survival. In fact, the
manner in which these stem cells grow
in culture reflects their organization in
the blastocyst; mESCs grow in disorga-
nized three-dimensional assemblages
similar to the inner cell mass, whereas
hESCs grow as tightly adherent two-
dimensional sheets similar to the epiblast
(Figure 1A). Interestingly, when human
induced pluripotent stem cells (hiPSCs)
were reprogrammed from fibroblasts
through the expression of five reprogram-
ming factors plus LIF, their ability to grow
at low density or in suspension was paral-
leled by the acquisition of mESC-like136 Cell Stem Cell 7, August 6, 2010 ª2010 Edisorganized three-dimensional growth
characteristics in vitro (Buecker et al.,
2010). The linkage of actomyosin contrac-
tion to intrinsic cell death mechanisms is
not universal; hESCs appear to be exqui-
sitely sensitive relative to other cell types.
This sensitivity may be a reflection of the
fundamental importance of proper differ-
entiation and organization of the epiblast
stage during embryonic development. If
a single cell in the epiblast were to be
improperly positioned in the epithelial
sheet, there could be dire consequences
to subsequent developmental stages
and ultimately to the whole organism.
Given that myosin contractility as well
as actin integrity were required for thelsevier Inc.induction of apoptosis by dis-
sociation, inhibition of addi-
tional targets that influence
actomyosin function, such as
the LIM kinases that act as
downstream effectors of
ROCK to modulate filamen-
tous actin stability (Scott and
Olson, 2007), may also pro-
mote hESC survival and
avoid affecting essential roles
of Rho and ROCK indepen-
dent of actin cytoskeleton
regulation. In addition to iden-
tifying some fundamental as-
pects of stem cell biology,
these reports will help to
more precisely home in on the
optimal conditions for pro-
pagating hESCs, aiding the
ultimate goal of generating
stem cells for therapeutic use.REFERENCES
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